Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
Motzer, Robert J, Rini, Brian I, McDermott, David F, Redman, Bruce G, Kuzel, Timothy M, Harrison, Michael R, Vaishampayan, Ulka N, Drabkin, Harry A, George, Saby, Logan, Theodore F, Margolin, Kim A, Plimack, Elizabeth R, Lambert, Alexandre M, Waxman, Ian M, Hammers, Hans J
Published in Journal of clinical oncology (01.05.2015)
Published in Journal of clinical oncology (01.05.2015)
Get full text
Journal Article
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial
Weber, Jeffrey S, Prof, Gibney, Geoff, MD, Sullivan, Ryan J, MD, Sosman, Jeffrey A, Prof, Slingluff, Craig L, Prof, Lawrence, Donald P, MD, Logan, Theodore F, MD, Schuchter, Lynn M, Prof, Nair, Suresh, MD, Fecher, Leslie, MD, Buchbinder, Elizabeth I, MD, Berghorn, Elmer, BSN, Ruisi, Mary, MD, Kong, George, PhD, Jiang, Joel, PhD, Horak, Christine, PhD, Hodi, F Stephen, Dr
Published in The lancet oncology (01.07.2016)
Published in The lancet oncology (01.07.2016)
Get full text
Journal Article
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
Margolin, Kim, Prof, Ernstoff, Marc S, MD, Hamid, Omid, MD, Lawrence, Donald, MD, McDermott, David, MD, Puzanov, Igor, MD, Wolchok, Jedd D, MD, Clark, Joseph I, Prof, Sznol, Mario, MD, Logan, Theodore F, MD, Richards, Jon, MD, Michener, Tracy, PharmD, Balogh, Agnes, MS, Heller, Kevin N, MD, Hodi, F Stephen, MD
Published in The lancet oncology (01.05.2012)
Published in The lancet oncology (01.05.2012)
Get full text
Journal Article
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
Armstrong, Andrew J, Dr, Halabi, Susan, Prof, Eisen, Tim, Prof, Broderick, Samuel, MS, Stadler, Walter M, Prof, Jones, Robert J, Prof, Garcia, Jorge A, MD, Vaishampayan, Ulka N, Prof, Picus, Joel, Prof, Hawkins, Robert E, Prof, Hainsworth, John D, Prof, Kollmannsberger, Christian K, Prof, Logan, Theodore F, Prof, Puzanov, Igor, MD, Pickering, Lisa M, MD, Ryan, Christopher W, MD, Protheroe, Andrew, MD, Lusk, Christine M, MPH, Oberg, Sadie, BS, George, Daniel J, Prof
Published in The lancet oncology (01.03.2016)
Published in The lancet oncology (01.03.2016)
Get full text
Journal Article
Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma
CHOUEIRI, Toni K, VAISHAMPAYAN, Ulka, OTTESEN, Lone H, LAUBSCHER, Kevin H, SHERMAN, Laurie, MCDERMOTT, David F, HAAS, Naomi B, FLAHERTY, Keith T, ROSS, Robert, EISENBERG, Peter, MELTZER, Paul S, MERINO, Maria J, ROSENBERG, Jonathan E, BOTTARO, Donald P, MARSTON LINEHAN, W, SRINIVASAN, Ramaprasad, LOGAN, Theodore F, HARZSTARK, Andrea L, BUKOWSKI, Ronald M, RINI, Brian I, SRINIVAS, Sandy, STEIN, Mark N, ADAMS, Laurel M
Published in Journal of clinical oncology (10.01.2013)
Published in Journal of clinical oncology (10.01.2013)
Get full text
Journal Article
Drug-Related Pneumonitis in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus
Maroto, Jose Pablo, Hudes, Gary, Dutcher, Janice P, Logan, Theodore F, White, Charles S, Krygowski, Mizue, Cincotta, Maria, Shapiro, Mark, Duran, Ignacio, Berkenblit, Anna
Published in Journal of clinical oncology (01.05.2011)
Published in Journal of clinical oncology (01.05.2011)
Get full text
Journal Article
Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma
ATKINS, Michael B, HIDALGO, Manuel, DUKART, Gary, SHERMAN, Matthew L, STADLER, Walter M, LOGAN, Theodore F, DUTCHER, Janice P, HUDES, Gary R, PARK, Young, LIOU, Song-Heng, MARSHALL, Bonnie, BONI, Joseph P
Published in Journal of clinical oncology (01.03.2004)
Published in Journal of clinical oncology (01.03.2004)
Get full text
Journal Article
Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma
McDermott, David F, Regan, Meredith M, Clark, Joseph I, Flaherty, Lawrence E, Weiss, Geoffery R, Logan, Theodore F, Kirkwood, John M, Gordon, Michael S, Sosman, Jeffrey A, Ernstoff, Marc S, Tretter, Christopher P G, Urba, Walter J, Smith, John W, Margolin, Kim A, Mier, James W, Gollob, Jared A, Dutcher, Janice P, Atkins, Michael B
Published in Journal of clinical oncology (01.01.2005)
Published in Journal of clinical oncology (01.01.2005)
Get full text
Journal Article
Discordancy in BRAF mutations among primary and metastatic melanoma lesions: clinical implications for targeted therapy
Bradish, Joshua R, Richey, Justin D, Post, Kristin M, Meehan, Kari, Sen, Joyashree D, Malek, Amanda J, Katona, Terrence M, Warren, Simon, Logan, Theodore F, Fecher, Leslie A, Cheng, Liang
Published in Modern pathology (01.04.2015)
Published in Modern pathology (01.04.2015)
Get full text
Journal Article
A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer
ROBERTSON, Michael J, KIRKWOOD, John M, LOGAN, Theodore F, KOCH, Kevin M, KATHMAN, Steven, KIRBY, Lyndon C, BELL, William N, THURMOND, Linda M, WEISENBACH, Jill, DAR, Mohammed M
Published in Clinical cancer research (01.06.2008)
Published in Clinical cancer research (01.06.2008)
Get full text
Journal Article
Pegylated Arginine Deiminase Treatment of Patients With Metastatic Melanoma: Results From Phase I and II Studies
ASCIERTO, Paolo A, SCALA, Stefania, ENSOR, C. Mark, PRESTAYKO, Archie W, HOLTSBERG, Frederick W, BOMALASKI, John S, CLARK, Mike A, SAVARAJ, Niramol, FEUN, Lynn G, LOGAN, Theodore F, CASTELLO, Giuseppe, DAPONTE, Antonio, SIMEONE, Ester, OTTAIANO, Alessandro, BENEDUCE, Gerardo, DE ROSA, Vincenzo, IZZO, Francesco, MELUCCI, Maria Teresa
Published in Journal of clinical oncology (20.10.2005)
Published in Journal of clinical oncology (20.10.2005)
Get full text
Journal Article
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
Chesney, Jason, Puzanov, Igor, Collichio, Frances, Singh, Parminder, Milhem, Mohammed M, Glaspy, John, Hamid, Omid, Ross, Merrick, Friedlander, Philip, Garbe, Claus, Logan, Theodore F, Hauschild, Axel, Lebbé, Celeste, Chen, Lisa, Kim, Jenny J, Gansert, Jennifer, Andtbacka, Robert H I, Kaufman, Howard L
Published in Journal of clinical oncology (10.06.2018)
Published in Journal of clinical oncology (10.06.2018)
Get full text
Journal Article
Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized Trial
CLARK, Joseph I, ATKINS, Michael B, WEISS, Geoffrey R, REDMAN, Bruce G, TRETTER, Christopher P. G, MCDERMOTT, David, SMITH, John W, GORDON, Michael S, MARGOLIN, Kim A, URBA, Walter J, CREECH, Steven, FIGLIN, Robert A, DUTCHER, Janice P, FLAHERTY, Larry, SOSMAN, Jeffrey A, LOGAN, Theodore F, WHITE, Richard
Published in Journal of clinical oncology (15.08.2003)
Published in Journal of clinical oncology (15.08.2003)
Get full text
Journal Article
Conference Proceeding
A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma
Clark, Joseph I, Singh, Jatinder, Ernstoff, Marc S, Lao, Christopher D, Flaherty, Lawrence E, Logan, Theodore F, Curti, Brendan, Agarwala, Sanjiv S, Taback, Bret, Cranmer, Lee, Lutzky, Jose, Luna, Theresa L, Aung, Sandra, Lawson, David H
Published in Journal for immunotherapy of cancer (27.07.2018)
Published in Journal for immunotherapy of cancer (27.07.2018)
Get full text
Journal Article
Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion
Ribas, Antoni, Chesney, Jason A, Gordon, Michael S, Abernethy, Amy P, Logan, Theodore F, Lawson, David H, Chmielowksi, Bartosz, Glaspy, John A, Lewis, Karl, Huang, Bo, Wang, Erjian, Hsyu, Poe-Hirr, Gomez-Navarro, Jesus, Gerhardt, Diana, Marshall, Margaret A, Gonzalez, Rene
Published in Journal of translational medicine (21.11.2012)
Published in Journal of translational medicine (21.11.2012)
Get full text
Journal Article
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF -Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134
Atkins, Michael B, Lee, Sandra J, Chmielowski, Bartosz, Tarhini, Ahmad A, Cohen, Gary I, Truong, Thach-Giao, Moon, Helen H, Davar, Diwakar, O'Rourke, Mark, Stephenson, Joseph J, Curti, Brendan D, Urba, Walter J, Brell, Joanna M, Funchain, Pauline, Kendra, Kari L, Ikeguchi, Alexandra P, Jaslowski, Anthony, Bane, Charles L, Taylor, Mark A, Bajaj, Madhuri, Conry, Robert M, Ellis, Robert J, Logan, Theodore F, Laudi, Noel, Sosman, Jeffrey A, Crockett, David G, Pecora, Andrew L, Okazaki, Ian J, Reganti, Sowjanya, Chandra, Sunandana, Guild, Samantha, Chen, Helen X, Streicher, Howard Z, Wolchok, Jedd D, Ribas, Antoni, Kirkwood, John M
Published in Journal of clinical oncology (10.01.2023)
Published in Journal of clinical oncology (10.01.2023)
Get full text
Journal Article
Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
Segal, Neil H, Logan, Theodore F, Hodi, F Stephen, McDermott, David, Melero, Ignacio, Hamid, Omid, Schmidt, Henrik, Robert, Caroline, Chiarion-Sileni, Vanna, Ascierto, Paolo A, Maio, Michele, Urba, Walter J, Gangadhar, Tara C, Suryawanshi, Satyendra, Neely, Jaclyn, Jure-Kunkel, Maria, Krishnan, Suba, Kohrt, Holbrook, Sznol, Mario, Levy, Ronald
Published in Clinical cancer research (15.04.2017)
Published in Clinical cancer research (15.04.2017)
Get full text
Journal Article
Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003
Dudek, Arkadiusz Z, Liu, Li C, Gupta, Shilpa, Logan, Theodore F, Singer, Eric A, Joshi, Monika, Zakharia, Yousef N, Lang, Joshua M, Schwarz, James K, Al-Janadi, Anas, Alva, Ajjai S
Published in Journal of clinical oncology (10.04.2020)
Published in Journal of clinical oncology (10.04.2020)
Get full text
Journal Article
Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry
Curti, Brendan, Daniels, Gregory A., McDermott, David F., Clark, Joseph I., Kaufman, Howard L., Logan, Theodore F., Singh, Jatinder, Kaur, Meenu, Luna, Theresa L., Gregory, Nancy, Morse, Michael A., Wong, Michael K. K., Dutcher, Janice P.
Published in Journal for immunotherapy of cancer (19.12.2017)
Published in Journal for immunotherapy of cancer (19.12.2017)
Get full text
Journal Article